nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.0375	0.0599	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.0296	0.0474	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.0293	0.0468	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.0231	0.037	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.0231	0.037	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.0219	0.035	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.0215	0.0344	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—TNF—leprosy	0.021	1	CrCbGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.0207	0.0332	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.0199	0.0317	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.0195	0.0311	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.0191	0.0305	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.0188	0.0301	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.0183	0.0292	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.0173	0.0277	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.017	0.0272	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.0164	0.0262	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.0157	0.0251	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.0154	0.0246	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.0151	0.0241	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.0149	0.0238	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.0149	0.0238	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—RIPK2—leprosy	0.0147	0.0236	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TLR2—leprosy	0.0147	0.0236	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NOD2—leprosy	0.0134	0.0214	CbGpPWpGaD
Hydroxychloroquine—Foetor hepaticus—Thalidomide—leprosy	0.0121	0.0343	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.0118	0.0188	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—RIPK2—leprosy	0.0117	0.0186	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TLR2—leprosy	0.0117	0.0186	CbGpPWpGaD
Hydroxychloroquine—Psoriasis—Thalidomide—leprosy	0.0109	0.031	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NOD2—leprosy	0.0106	0.0169	CbGpPWpGaD
Hydroxychloroquine—Liver disorder—Thalidomide—leprosy	0.0101	0.0286	CcSEcCtD
Hydroxychloroquine—Nystagmus—Thalidomide—leprosy	0.00963	0.0273	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Dapsone—leprosy	0.00952	0.027	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Dapsone—leprosy	0.0086	0.0243	CcSEcCtD
Hydroxychloroquine—Blood disorder—Thalidomide—leprosy	0.00823	0.0233	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Dapsone—leprosy	0.00769	0.0218	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Thalidomide—leprosy	0.00761	0.0216	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CYLD—leprosy	0.00741	0.0118	CbGpPWpGaD
Hydroxychloroquine—Hearing impaired—Thalidomide—leprosy	0.00722	0.0205	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Thalidomide—leprosy	0.00688	0.0195	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Thalidomide—leprosy	0.00646	0.0183	CcSEcCtD
Hydroxychloroquine—Tinnitus—Dapsone—leprosy	0.00629	0.0178	CcSEcCtD
Hydroxychloroquine—Lightheadedness—Thalidomide—leprosy	0.00615	0.0174	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CYLD—leprosy	0.00586	0.00936	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity—Thalidomide—leprosy	0.00568	0.0161	CcSEcCtD
Hydroxychloroquine—Deafness—Thalidomide—leprosy	0.00558	0.0158	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.00557	0.00891	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Dapsone—leprosy	0.00553	0.0157	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Thalidomide—leprosy	0.00529	0.015	CcSEcCtD
Hydroxychloroquine—Vertigo—Dapsone—leprosy	0.00528	0.0149	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Thalidomide—leprosy	0.00527	0.0149	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Thalidomide—leprosy	0.00522	0.0148	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Thalidomide—leprosy	0.00511	0.0145	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Thalidomide—leprosy	0.00511	0.0145	CcSEcCtD
Hydroxychloroquine—Affect lability—Thalidomide—leprosy	0.00491	0.0139	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Thalidomide—leprosy	0.00488	0.0138	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—RIPK2—leprosy	0.00478	0.00763	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TLR2—leprosy	0.00478	0.00763	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Thalidomide—leprosy	0.00473	0.0134	CcSEcCtD
Hydroxychloroquine—Ataxia—Thalidomide—leprosy	0.00469	0.0133	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Thalidomide—leprosy	0.00461	0.013	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.0045	0.0127	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.00441	0.00704	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Thalidomide—leprosy	0.0044	0.0125	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.00435	0.00695	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NOD2—leprosy	0.00433	0.00692	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CYLD—leprosy	0.00432	0.0069	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Thalidomide—leprosy	0.00427	0.0121	CcSEcCtD
Hydroxychloroquine—Bronchospasm—Thalidomide—leprosy	0.00424	0.012	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Thalidomide—leprosy	0.0041	0.0116	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Thalidomide—leprosy	0.00394	0.0111	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dapsone—leprosy	0.00392	0.0111	CcSEcCtD
Hydroxychloroquine—Weight decreased—Thalidomide—leprosy	0.0039	0.0111	CcSEcCtD
Hydroxychloroquine—Drowsiness—Thalidomide—leprosy	0.00385	0.0109	CcSEcCtD
Hydroxychloroquine—Depression—Thalidomide—leprosy	0.00384	0.0109	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PARK2—leprosy	0.00382	0.0061	CbGpPWpGaD
Hydroxychloroquine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00381	0.0108	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dapsone—leprosy	0.00379	0.0107	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dapsone—leprosy	0.00379	0.0107	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—RIPK2—leprosy	0.00378	0.00603	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TLR2—leprosy	0.00378	0.00603	CbGpPWpGaD
Hydroxychloroquine—Agranulocytosis—Thalidomide—leprosy	0.00359	0.0102	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.00344	0.0055	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NOD2—leprosy	0.00342	0.00547	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CYLD—leprosy	0.00341	0.00545	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Thalidomide—leprosy	0.00333	0.00942	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Thalidomide—leprosy	0.00327	0.00924	CcSEcCtD
Hydroxychloroquine—Eye disorder—Thalidomide—leprosy	0.00323	0.00914	CcSEcCtD
Hydroxychloroquine—Tinnitus—Thalidomide—leprosy	0.00322	0.00912	CcSEcCtD
Hydroxychloroquine—Alopecia—Thalidomide—leprosy	0.00305	0.00864	CcSEcCtD
Hydroxychloroquine—Vomiting—Dapsone—leprosy	0.00305	0.00863	CcSEcCtD
Hydroxychloroquine—Mental disorder—Thalidomide—leprosy	0.00303	0.00857	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PARK2—leprosy	0.00302	0.00482	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Thalidomide—leprosy	0.00301	0.00851	CcSEcCtD
Hydroxychloroquine—Headache—Dapsone—leprosy	0.003	0.0085	CcSEcCtD
Hydroxychloroquine—Tension—Thalidomide—leprosy	0.00295	0.00835	CcSEcCtD
Hydroxychloroquine—Nervousness—Thalidomide—leprosy	0.00292	0.00827	CcSEcCtD
Hydroxychloroquine—Nausea—Dapsone—leprosy	0.00285	0.00806	CcSEcCtD
Hydroxychloroquine—Vision blurred—Thalidomide—leprosy	0.00283	0.00802	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—RIPK2—leprosy	0.00278	0.00445	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TLR2—leprosy	0.00278	0.00445	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Thalidomide—leprosy	0.00278	0.00787	CcSEcCtD
Hydroxychloroquine—Agitation—Thalidomide—leprosy	0.00276	0.00782	CcSEcCtD
Hydroxychloroquine—Angioedema—Thalidomide—leprosy	0.00275	0.00778	CcSEcCtD
Hydroxychloroquine—Vertigo—Thalidomide—leprosy	0.0027	0.00765	CcSEcCtD
Hydroxychloroquine—Leukopenia—Thalidomide—leprosy	0.00269	0.00762	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Thalidomide—leprosy	0.00264	0.00748	CcSEcCtD
Hydroxychloroquine—Convulsion—Thalidomide—leprosy	0.0026	0.00737	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00254	0.0072	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—NOD2—leprosy	0.00252	0.00403	CbGpPWpGaD
Hydroxychloroquine—Oedema—Thalidomide—leprosy	0.00245	0.00695	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Thalidomide—leprosy	0.00241	0.00681	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Thalidomide—leprosy	0.0024	0.0068	CcSEcCtD
Hydroxychloroquine—Skin disorder—Thalidomide—leprosy	0.00238	0.00675	CcSEcCtD
Hydroxychloroquine—Anorexia—Thalidomide—leprosy	0.00234	0.00662	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TLR2—leprosy	0.0022	0.00351	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RIPK2—leprosy	0.0022	0.00351	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Thalidomide—leprosy	0.00218	0.00618	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Thalidomide—leprosy	0.00213	0.00604	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD40LG—leprosy	0.00213	0.00341	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Thalidomide—leprosy	0.00212	0.006	CcSEcCtD
Hydroxychloroquine—Fatigue—Thalidomide—leprosy	0.00212	0.00599	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD8A—leprosy	0.00211	0.00337	CbGpPWpGaD
Hydroxychloroquine—Pain—Thalidomide—leprosy	0.0021	0.00594	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CD4—leprosy	0.00208	0.00332	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Thalidomide—leprosy	0.00201	0.00568	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NOD2—leprosy	0.00199	0.00319	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Thalidomide—leprosy	0.00195	0.00552	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Thalidomide—leprosy	0.00194	0.00549	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Thalidomide—leprosy	0.00194	0.00549	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Thalidomide—leprosy	0.00181	0.00512	CcSEcCtD
Hydroxychloroquine—Asthenia—Thalidomide—leprosy	0.00176	0.00498	CcSEcCtD
Hydroxychloroquine—Pruritus—Thalidomide—leprosy	0.00174	0.00491	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-DRB1—leprosy	0.00172	0.00274	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD40LG—leprosy	0.00169	0.00269	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Thalidomide—leprosy	0.00168	0.00475	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD8A—leprosy	0.00167	0.00266	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD4—leprosy	0.00164	0.00263	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Thalidomide—leprosy	0.00162	0.00459	CcSEcCtD
Hydroxychloroquine—Vomiting—Thalidomide—leprosy	0.00156	0.00442	CcSEcCtD
Hydroxychloroquine—Rash—Thalidomide—leprosy	0.00155	0.00438	CcSEcCtD
Hydroxychloroquine—Dermatitis—Thalidomide—leprosy	0.00155	0.00438	CcSEcCtD
Hydroxychloroquine—Headache—Thalidomide—leprosy	0.00154	0.00435	CcSEcCtD
Hydroxychloroquine—Nausea—Thalidomide—leprosy	0.00146	0.00413	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—RIPK2—leprosy	0.00142	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-DRB1—leprosy	0.00136	0.00217	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNG—leprosy	0.00125	0.002	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD4—leprosy	0.00121	0.00193	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—leprosy	0.00111	0.00178	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNG—leprosy	0.000991	0.00158	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD4—leprosy	0.000957	0.00153	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—leprosy	0.000881	0.00141	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—leprosy	0.000569	0.00091	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SDHD—leprosy	0.000467	0.000746	CbGpPWpGaD
